Enzyme involved in purine and pyrimidine synthesis

Enzymes involved in **purine and pyrimidine synthesis** are responsible for the de novo creation and salvage recycling of nucleotides required for DNA and RNA production. These multi-step biochemical pathways are essential for cell survival, proliferation, genetic information transfer, energy storage/transfer, signaling molecules production, and more. The **purine pathway** includes key enzymes such as glutamine phosphoribosylpyrophosphate amidotransferase ("GPAT"), phosphoribosylamine—glycine ligase ("GAR synthetase"), inosinate dehydrogenase ("IMPDH"), adenylosuccinate synthetase/lyase, among others. The **pyrimidine pathway** features carbamoyl phosphate synthetase II ("CPS II"), aspartate transcarbamoylase ("ATCase"), dihydroorotase/dihydroorotate dehydrogenase ("DHODH"), orotate phosphoribosyltransferase/OMP decarboxylase. These enzymatic steps are tightly regulated by feedback mechanisms involving end products like AMP/GMP/UTP. Many chemotherapeutics exploit this dependency by inhibiting one or more critical steps—leading to cytostatic/cytotoxic effects especially pronounced in rapidly dividing cells such as cancerous tissue or activated immune cells[2][4][8]. However, because normal proliferating tissues also require active nucleotide biosynthesis (e.g., bone marrow), therapeutic targeting carries substantial risk. In summary: "enzymes involved in purine and pyrimidine synthesis" is not a single target but rather an umbrella term covering numerous individual enzymatic proteins that collectively enable cellular life through nucleotide generation. Each has unique properties relevant to disease biology and pharmacology but should be specified individually when possible for structured data applications[1][4][7].

Other names

Purine biosynthetic enzymePyrimidine biosynthetic enzymeNucleotide synthesis enzymeDe novo nucleotide synthesis enzyme

Varies by drug/enzyme targeted; examples include: - Competitive inhibition of key synthetic steps - Allosteric inhibition or feedback regulation - Antimetabolite incorporation into nucleic acids causing chain termination or faulty replication